Patients with multiple sclerosis who develop immunogenicity to interferon-beta have distinct transcriptomic and proteomic signatures prior to treatment which are associated with disease severity

Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 267(2024) vom: 01. Okt., Seite 110339
1. Verfasser: Coelewij, Leda (VerfasserIn)
Weitere Verfasser: Adriani, Marsilio, Dönnes, Pierre, Waddington, Kirsty E, Ciurtin, Coziana, Havrdova, Eva Kubala, ABIRISK Consortium, Farrell, Rachel, Nytrova, Petra, Pineda-Torra, Inés, Jury, Elizabeth C
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2024
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Anti-drug antibodies Biomarkers Immunogenicity Multiple sclerosis Progression Interferon-beta 77238-31-4